Single-Use Bioreactor Mixing Control Patents: Leaders & Trends 2026
Single-Use Bioreactor Mixing Control Patents: Who Holds the Claims
45.1% of all 450 records sit with just five assignees, making the top of this field genuinely concentrated rather than fragmented. Filings rose to a peak of 65 in 2023, then declined 48% from 23 filings in 2021 to 12 in 2024 — the last year with a complete publication record. Earlier years such as 2017 (23 filings) show the field was already active before the recent peak.
- 1GLOBAL LIFE SCIENCES SOLUTIONS USA LLC67
- 2REGENERON PHARMACEUTICALS INC54
- 3JUST EVOTEC BIOLOGICS INC29
- 4OMNIBRX BIOTECHNOLOGIES PTE LTD29
- 5UNIVERCELLS SA24
See the full single-use bioreactor mixing control analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Frequently asked questions
Who holds the most patents on single-use bioreactor mixing control?
One assignee leads the field with 67 of the 450 records in scope, well ahead of the fifth-ranked holder at 24 records and tenth place at 15. The top five assignees combined hold 45.1% of all 450 records, making this a concentrated field at the top even though the full ranking runs to 93 companies. Anyone evaluating freedom-to-operate should start by reviewing the leading assignees’ full claim sets before widening the search to the long tail.
Is patent filing in single-use bioreactor mixing control still growing?
Filing peaked at 65 records in 2023 and then fell 48% from 23 filings in 2021 to 12 in 2024, the last year with a complete publication record. Because publication typically lags filing by around 18 months, the lower figures shown for 2025 and 2026 are provisional and should not yet be read as a continued decline. The honest read is that the field filed heavily around a design wave through 2023 and appears to be consolidating, pending confirmation from later data cuts.
What technology areas overlap most with mixing control claims?
Within the 450 records, B01F mixing and stirring classes appear in 18.4% of filings, nearly matching C07K peptide and protein classes at 18.7%. C12N microorganism and genetic engineering claims appear in 10.4% of records and C12P fermentation claims in 7.6%, with separation (B01D), catalysis (B01J) and lab apparatus (B01L) each under 6%. Because a single record can carry multiple IPC classes, these shares add up to more than 100% and should be read as overlap patterns, not a partition of the field.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Single-Use Bioreactor Mixing Control covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.